These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2970916)

  • 21. Frequency of insulin-dependent diabetes mellitus in Turkish adult-onset diabetic population.
    Gürlek A; Erbaş T; Sayinalp S; Gedik O
    Acta Diabetol; 1996 Sep; 33(3):216-9. PubMed ID: 8904928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.
    Karjalainen J; Knip M; Hyöty H; Leinikki P; Ilonen J; Käär ML; Akerblom HK
    Diabetologia; 1988 Mar; 31(3):146-52. PubMed ID: 3286341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of islet cell antibodies, insulin antibodies and hyperglycaemia in 2291 schoolchildren.
    Bergua M; Solé J; Marion G; Perez MC; Recasens A; Fernàndez J; Casamitjana R; Gomis R
    Diabetologia; 1987 Sep; 30(9):724-6. PubMed ID: 3322914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies to insulin have similar affinity to that of antibodies to exogenous insulin but lower binding capacity.
    Vähäsalo P
    Eur J Clin Invest; 1992 Dec; 22(12):772-6. PubMed ID: 1478247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth.
    Ziegler AG; Hillebrand B; Rabl W; Mayrhofer M; Hummel M; Mollenhauer U; Vordemann J; Lenz A; Standl E
    Diabetologia; 1993 May; 36(5):402-8. PubMed ID: 8314444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L; Korányi L; Tamás G
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow-cytometric detection of human anti-rat insulinoma antibodies in relation to anti-human islet cell and anti-insulin antibodies. Recognition of distinct antigens by antibodies in early type I diabetes.
    Lander T; Nerl C; Held M; Standl E; Mehnert H
    Diabetes; 1989 Dec; 38(12):1557-66. PubMed ID: 2555242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.
    Dotta F; Eisenbarth GS
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S85-95. PubMed ID: 2642771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of B-cell function by the urinary excretion rate of C-peptide in diabetic patients: comparison with C-peptide response to glucagon and to a mixed meal.
    Pasquali R; Buratti P; Biso P; Patrono D; Capelli M; Pasqui F; Melchionda N
    Diabete Metab; 1987 Feb; 13(1):44-51. PubMed ID: 3552774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children.
    Sochett EB; Daneman D; Clarson C; Ehrlich RM
    Diabetologia; 1987 Jul; 30(7):453-9. PubMed ID: 3311859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.
    Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK
    Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary C-peptide: a useful tool for evaluating the endogenous insulin reserve in cohort and longitudinal studies of diabetes in childhood.
    de Beaufort CE; den Boer NC; Bruining GJ; Eilers GA; van Strik R; Weterings T
    Ann Clin Biochem; 1988 Sep; 25 ( Pt 5)():552-9. PubMed ID: 3069047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet antibodies associated with pancreatic B-cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old.
    Berger B; Borg H; Fernlund P; Stenström G; Sundkvist G
    Diabet Med; 2006 Nov; 23(11):1180-5. PubMed ID: 17054592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells].
    Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I
    Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-insulin antibodies in children with type I diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement.
    McEvoy RC; Witt ME; Ginsberg-Fellner F; Rubinstein P
    Diabetes; 1986 Jun; 35(6):634-41. PubMed ID: 3519320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.